Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of a novel measure of advanced cancer patients’ perceived utility of secondary germline findings from tumor genomic profiling

PEC Innovation(2023)10.1016/j.pecinn.2023.100124Source: DataRank Database

Development of a novel measure of advanced cancer patients’ perceived utility of secondary germline findings from tumor genomic profiling is a research paper published in PEC Innovation (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: goldTopics (12)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Ibrahim H. Shah,C.M. Salafia ORCID,Elizabeth Schofield ORCID,Margaux Genoff Garzon,Kechna Cadet ORCID

Live enrichment

PubMed:37214538 PMC:PMC10194097

American Cancer Society

Grant: MRSG-16-020-01-CPPB

National Cancer Institute

Grant: NCI P30 CA008748

NCI NIH HHS

Grant: P30 CA008748

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

National Institutes of Health

goldLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1016/j.pecinn.2023.100124

publisherhttps://api.elsevier.com/content/article/PII:S2772628223000043?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2772628223000043?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10194097/pdf/main.pdf

repositoryhttps://doaj.org/article/c0a7827d6e7e4c30a8a5db78f5cba818

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

OncologyGenetic TestingGenomic SequencingPerceived UtilityIncidental Germline FindingsSecondary Germline FindingsTumor-Normal AnalysisArticles from Special issue on Communication in Genomic and Precision Medicine; Edited by Gemme Campbell-SalomePublic aspects of medicineRA1-1270